Russian AI Akkofrisk to Assess Women’s Cancer Risks
The system runs a multi-system analysis before delivering its verdict.
In Russia, artificial intelligence has begun assessing women’s risk of developing breast and cervical cancer. The platform, Akkofrisk, analyzes how multiple systems in the body are functioning - including the heart, blood vessels, liver, kidneys, metabolism, hormones, sleep, and stress - and draws conclusions based on that data. Some of those conclusions can be troubling.
The AI conducts a multi-system review. It models hormone-dependent risks, evaluates microcirculation and hemodynamics, detects imbalances in the autonomic nervous system, and indirectly assesses systemic inflammation, among other indicators. Before issuing a final assessment, the system also adjusts its findings to account for the patient’s lifestyle.
Early Detection Is Key to Successful Treatment
The company plans to expand its predictive AI work further and add risk assessments for other types of cancer.
Earlier, we reported that Russian scientists had developed a biosensor capable of diagnosing cancer in just five minutes. The technology, already being tested in Moscow clinics, is said to be 1,000 times more sensitive than foreign counterparts and could reshape approaches to early cancer detection worldwide.
